Phase I study of AZD1775 with radiation therapy (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM) and evaluation of intratumoral drug distribution (IDD) in patients with recurrent GBM Meeting Abstract


Authors: Alexander, B.; Supko, J.; Agar, N.; Ahluwalia, M.; Desai, A.; Dietrich, J.; Kaley, T.; Peereboom, D.; Takebe, N.; Desideri, S.; Fisher, J.; Sims, M.; Ye, X.; Ligon, K.; Nabors, L. B.; Grossman, S.; Wen, P.
Abstract Title: Phase I study of AZD1775 with radiation therapy (RT) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM) and evaluation of intratumoral drug distribution (IDD) in patients with recurrent GBM
Meeting Title: 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology
Journal Title: Neuro-Oncology
Volume: 20
Issue: Suppl. 6
Meeting Dates: 2018 Nov 15-18
Meeting Location: New Orleans, LA
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2018-11-01
Start Page: vi13
End Page: vi14
Language: English
ACCESSION: WOS:000460646300050
PROVIDER: wos
PMCID: PMC6216117
DOI: 10.1093/neuonc/noy148
Notes: Meeting Abstract: ACTR-14 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Thomas Kaley
    156 Kaley